Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic

JAMA Oncol. 2020 Oct 1;6(10):1630-1632. doi: 10.1001/jamaoncol.2020.3545.

Abstract

This cohort study uses National Cancer Database data from 2004 to 2014 to examine the association between overall survival and timing of radiotherapy relative to androgen deprivation therapy in patients with prostate cancer.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Antagonists / administration & dosage*
  • Androgens / metabolism
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / virology
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / virology
  • SARS-CoV-2

Substances

  • Androgen Antagonists
  • Androgens